Protocolo de tratamiento del ictus hemorrágico en fase aguda

  1. Muñoz-Lopetegi, A.
  2. de Arce, A.
  3. Martínez-Zabaleta, M.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2019

Series: 12

Issue: 70

Pages: 4138-4142

Type: Article

DOI: 10.1016/J.MED.2019.01.008 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Because the morbility and mortality rates of intracerebral hemorrhage (ICH) are high and show an uncertain initial prognosis, its clinical management in the acute phase has to be aggressive. The treatment is mainly focused to prevent hematoma expansion and intracranial hypertension (IIH). In order to prevent severe complications, all emergency treatments should be carried out at neurologic/neurosurgical intensive care unit. The adequate management of blood pressure, the rapid reversal of anticoagulation and prevention and treatment of ICH are essential. Large cerebellar or life-threatening cerebellar hematomas should be evacuated urgently. Nevertheless, because surgical indication does not improve functional outcome, its use controversial and has to be tailored in supratentorial ICH. Minimally invasive surgery shows promising results and it might indicate the path to follow in the future.

Bibliographic References

  • Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C. Rapid blood pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355.
  • Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375:1131.
  • Hanley DF, Thompson RE, Muschelli J, Rosenblum M, McBee N, Lane K. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open label, phase 2 trial. Lancet Neurol. 2016; 15:1228.
  • Hemphill JC 3rd. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association / American Stroke As-sociation. Stroke. 2015;46(7):2032-60.
  • Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. Early surgery versus initial conservative treatment in patients with spontaneous supraten-torial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382:97.
  • Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA. Idarucizumab for dabigatran reversal full cohort analysis. N Engl J Med. 2017;377:431.
Data source: Dialnet